Prescribing inconsistencies in prostate cancer treatment in the UK when using LHRHAs EurekAlert!
Prostate cancer is the most common form of cancer in men in the UK with over 31,923 new cases diagnosed in 2002.[12] Off-label prescribing’ refers to any prescription that is not within the strict terms approved by the Medicines and Healthcare Product Regulatory Agency (MHRA), which are based on the quality, safety and efficacy of the product.
Prostate Treatment for Elderly Good News for Intuitve Surgical SeekingAlpha via Yahoo! Finance
Travis Johnson submits: An interesting study was released this week in the Journal of the American Medical Association that might mean the market for prostate surgery is going to get bigger -- which would mean good things for the makers of the da Vinci surgical robot, Intuitive Surgical .
Hunt, 74, a sports visionary Fort Worth Star-Telegram
Lamar Hunt, a pioneer whose innovations helped revolutionize the American sports culture, died Wednesday night at Presbyterian Hospital of Dallas after a long battle with prostate cancer. He was 74.
Stool DNA Testing For Colon Cancer Science Daily
A prospective, multi-center study of stool DNA testing has found that a new test demonstrated an 88 percent sensitivity for colorectal cancer, and with equal detection across all stages of cancer, regardless of the cancer's location in the colon. The study was published online in the American Gastroenterological Association's journal, Clinical Gastroenterology and Hepatology.
Indevus Pharma to buy Valera for $120M Sharewatch
The two companies also entered into a co-promotion agreement under which Indevus\' sales force will co-promote Vantas, a treatment for advanced prostate cancer, in the United States.
EDAP Strengthens UK, German Sales Teams; Proven Senior Professionals Added in Growth Markets RedNova
LYON, France, Dec. 13 /PRNewswire-FirstCall/ -- EDAP TMS S.A. , the global leader in High Intensity Focused Ultrasound (HIFU) treatment of prostate cancer, reports the appointment of Mark Perry as Senior Sales Director in charge of the United Kingdom.
EDAP Strengthens UK, German Sales Teams; Proven Senior Professionals Added in Growth Markets PR Newswire via Yahoo! Finance
EDAP TMS S.A. , the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, reports the appointment of Mark Perry as Senior Sales Director in charge of the United Kingdom.
New England Journal of Medicine Publishes Data from Pivotal Study of Avastin Plus Chemotherapy in Most Common Type of PR Newswire via Yahoo! Finance
Genentech, Inc. announced today the publication of data from a pivotal Phase III clinical trial in the New England Journal of Medicine showing that Avastin® in combination with paclitaxel and carboplatin chemotherapy significantly improved overall survival in patients with unresectable, locally advanced, recurrent or metastatic non-squamous, non- small cell lung cancer , the most common type of
First Familial Pancreatic Cancer Gene Identified Science Daily
At least 10 percent of pancreatic cancers are thought to be familial, i.e., caused by inherited genetic mutations. The responsible genes have so far remained elusive, but one of the research teams that had been on a pancreatic cancer gene hunt for years now reports success: Teri Brentnall (University of Washington), David Whitcomb (University of Pittsburgh), and colleagues publish the
New Year's Resolution No. 1: Prevent Cancer, Use Olive Oil Science Daily
In a study to be published in the January 2007 issue of the FASEB Journal, scientists from Europe countries describe how the anti-cancer effects of olive oil may account for the significant difference in cancer rates among Northern and Southern Europeans. This conclusion is based on the outcomes of volunteers from Denmark, Finland, Germany, Italy and Spain, who consumed 25 milliliters (a little
advanced+cancer+prostate: 2b advanced cancer mortality prostate , advanced cancer prostate symptom , 2b advanced cancer mortality prostate , advanced cancer prostate symptom , advanced+cancer+prostate